Laparoscopic duodenal de-rotation surgery provides durable symptom relief for most children with superior mesenteric artery syndrome, with 93% experiencing either complete resolution or significant improvement of their blockage symptoms over nearly 3 years. According to Gram Research analysis of 15 pediatric cases, children recovered quickly, going home after an average of 5.3 days, and showed healthy weight gain following surgery.
A rare condition called superior mesenteric artery syndrome (SMAS) can block a child’s small intestine and make eating painful. Researchers studied 15 children who had a minimally invasive surgery called laparoscopic duodenal de-rotation to fix the problem. According to Gram Research analysis, most kids felt significantly better after surgery, with 93% experiencing either complete relief or improvement in their symptoms. The surgery was safe, didn’t require conversion to open surgery, and kids went home after about 5 days. This research shows the procedure works well over the long term, helping children return to normal eating and healthy weight gain.
Key Statistics
A 2026 case series of 15 children found that laparoscopic duodenal de-rotation for superior mesenteric artery syndrome resulted in complete symptom relief in 33% of patients and improvement in 60%, with 93% overall showing either complete or significant symptom improvement.
In a 2026 study of 15 children undergoing laparoscopic duodenal de-rotation for SMAS, median hospital stay was 5.3 days and only 1 child (7%) required reoperation during an average 35-month follow-up period.
A 2026 analysis of 15 pediatric SMAS patients showed median BMI increased from 15.1 kg/m² before surgery to 17.1 kg/m² at final follow-up, indicating successful nutritional recovery after laparoscopic duodenal de-rotation.
The Quick Take
- What they studied: Whether a minimally invasive surgery can safely and effectively treat a rare condition that blocks children’s small intestines
- Who participated: 15 children (7 boys and 8 girls) ranging from 5 to 16 years old, with a median age of 13.3 years, all diagnosed with superior mesenteric artery syndrome
- Key finding: After surgery, 33% of children had complete relief from symptoms and 60% showed significant improvement, with results lasting an average of nearly 3 years
- What it means for you: If your child has been diagnosed with SMAS and conservative treatment hasn’t worked, this minimally invasive surgery appears to be a safe and effective option that avoids more invasive procedures
The Research Details
Researchers reviewed medical records from 15 children who had laparoscopic duodenal de-rotation surgery between 2016 and 2025 at two major children’s hospitals. For cases from 2016-2022, they looked back at existing medical records (called a retrospective review). For cases from 2023 onward, they collected information as it happened (called prospective collection). This mixed approach allowed them to gather detailed information about how well the surgery worked over time.
The surgery itself is a minimally invasive procedure, meaning doctors use small cameras and instruments inserted through tiny cuts instead of making one large incision. The goal is to reposition the duodenum (the first part of the small intestine) to relieve the blockage caused by the superior mesenteric artery pressing on it.
Researchers tracked several important measures: whether symptoms improved, how long children stayed in the hospital, what complications occurred, and changes in body weight and BMI over time. They followed children for a median of 35 months (nearly 3 years) to see if improvements lasted.
This research matters because SMAS is a rare condition that can significantly affect children’s quality of life, causing pain, nausea, and difficulty eating. While doctors have known about this surgery for a while, most information came from single case reports rather than systematic studies. By looking at multiple cases over nearly a decade, researchers could determine whether the surgery consistently works and whether benefits last long-term. This helps doctors and families make informed decisions about treatment.
This is a case report study, which is considered lower on the evidence hierarchy than randomized controlled trials, but it’s appropriate for rare conditions where large trials are difficult to conduct. The study combined both retrospective and prospective data collection, which strengthens reliability. All 15 patients completed the surgery without needing conversion to open surgery, suggesting the procedure was technically successful. The long follow-up period (median 35 months) is a significant strength, as it shows whether improvements were durable. However, the small sample size and lack of a comparison group (children who didn’t have surgery) means we can’t definitively say this is better than other treatments.
What the Results Show
The surgery was successful in all 15 children without requiring conversion to open surgery. Children started eating clear liquids just 2 days after surgery and went home after an average of 5.3 days in the hospital. When followed for nearly 3 years on average, the results were encouraging: 5 children (33%) experienced complete relief from their obstructive symptoms, meaning they had no more pain or difficulty eating. An additional 9 children (60%) showed significant improvement in their symptoms, though they may have had occasional mild issues. Combined, 93% of children either completely resolved or substantially improved their symptoms.
Beyond symptom relief, children’s nutritional status improved markedly. Their median BMI increased from 15.1 kg/m² before surgery to 17.1 kg/m² at final follow-up, indicating healthy weight gain and better nutrition. This is important because children with SMAS often struggle to eat enough and may be underweight.
Complications were minimal. Only 1 child (7%) required a second surgery, and this was due to gastrointestinal dysmotility (difficulty with normal intestinal movement), not failure of the original procedure. This low complication rate is notable because it suggests the minimally invasive approach is safe.
The quick return to eating (clear liquids by day 2) and short hospital stay (average 5.3 days) indicate that the minimally invasive approach causes minimal trauma to the body. Children recovered quickly and could go home to continue healing. The improvement in BMI suggests that beyond symptom relief, children could actually eat more and gain weight normally, addressing a major quality-of-life issue for kids with SMAS. The fact that only one child needed reoperation over nearly 3 years of follow-up suggests the surgery provides durable, lasting relief rather than temporary improvement.
Previous research on SMAS surgery mostly consisted of individual case reports showing short-term success. This study is significant because it’s one of the first to systematically evaluate intermediate-term outcomes (nearly 3 years) in a small series of pediatric patients. The 93% symptom improvement rate is consistent with or better than what’s been reported in smaller case reports. The low complication rate and minimal need for reoperation align with the safety profile suggested by earlier studies, but this research provides stronger evidence by following more patients over longer periods.
The main limitation is the small sample size of only 15 children, which makes it harder to draw firm conclusions. There’s no comparison group of children who received other treatments or no treatment, so we can’t definitively say this surgery is better than alternatives. The study combines data collected in different ways (retrospective and prospective), which could introduce inconsistencies. The study was conducted at only 2 hospitals, so results may not apply to all settings. Finally, 35 months is good follow-up, but longer-term data (5+ years) would be valuable to ensure benefits persist.
The Bottom Line
For children diagnosed with SMAS who have tried conservative treatment (like dietary changes and medications) for at least several months without adequate relief, laparoscopic duodenal de-rotation appears to be a reasonable surgical option. The evidence suggests a high likelihood (93%) of symptom improvement with low complication rates. Moderate confidence: This recommendation is based on a small case series rather than a large randomized trial, but the consistent results and long follow-up period provide reasonable support.
This research is most relevant to: (1) Children diagnosed with SMAS whose symptoms aren’t controlled with conservative treatment; (2) Parents and families considering surgical options; (3) Pediatric surgeons deciding on treatment approaches; (4) Gastroenterologists managing SMAS patients. This research is less relevant to adults with SMAS or children with other causes of intestinal obstruction.
Based on this study, most children showed improvement within the first few weeks after surgery (able to eat by day 2, home by day 5). Symptom improvement was maintained over the 35-month follow-up period, suggesting benefits are durable and not temporary. Full nutritional recovery (reflected in BMI improvement) likely takes several months as children gradually increase food intake and regain weight.
Frequently Asked Questions
What is superior mesenteric artery syndrome and why does it cause problems in children?
SMAS occurs when a blood vessel (the superior mesenteric artery) compresses the duodenum, the first part of the small intestine. This blockage prevents food from passing through normally, causing pain, nausea, vomiting, and difficulty eating. It’s rare but can significantly impact a child’s nutrition and quality of life.
How long does it take to recover from laparoscopic duodenal de-rotation surgery?
Most children go home within 5-6 days after surgery. They can start eating clear liquids within 2 days. Full recovery typically takes several weeks, with gradual return to normal diet and activities. The minimally invasive approach means less tissue damage and faster healing than traditional open surgery.
What percentage of children feel better after this surgery for SMAS?
According to a 2026 study of 15 children, 93% experienced either complete relief (33%) or significant improvement (60%) in their blockage symptoms. Only 1 child required a second surgery during the nearly 3-year follow-up period, indicating the procedure provides lasting relief.
Are there risks or complications from laparoscopic duodenal de-rotation?
Complications are rare with this minimally invasive approach. In the 2026 study of 15 children, only 1 child (7%) needed reoperation, which was due to intestinal movement problems rather than surgical failure. The procedure avoids the risk of anastomotic leakage that occurs with other surgical approaches.
How long do the benefits of this surgery last for SMAS?
The 2026 study followed children for an average of 35 months (nearly 3 years) and found symptom improvement was durable and sustained. Children also showed continued healthy weight gain, suggesting long-term nutritional benefits. Longer follow-up studies would help confirm if benefits persist beyond 3 years.
Want to Apply This Research?
- Track daily symptom severity (pain, nausea, difficulty eating) on a 1-10 scale before surgery and weekly for 3 months post-surgery, then monthly. Also monitor weight and BMI monthly to ensure healthy weight gain is occurring.
- Users can log meals eaten, portion sizes, and any symptoms experienced after eating. This helps identify which foods are tolerated best and tracks dietary progression from clear liquids to regular foods, providing concrete evidence of improvement.
- Create a long-term symptom diary tracking good days vs. difficult days, energy levels, and ability to participate in normal activities. Set monthly weight check-ins and compare to baseline. Alert users to contact their doctor if symptoms return or worsen after initial improvement.
This research describes outcomes from a small case series of 15 children and should not be considered definitive medical advice. SMAS is a rare condition requiring specialized diagnosis and treatment. Parents and caregivers should discuss all treatment options, including conservative management and surgical approaches, with their child’s pediatric gastroenterologist or surgeon. Individual outcomes may vary based on specific patient factors. This article is for educational purposes and does not replace professional medical consultation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
